Warfarin is a mainstay of therapy for conditions associated with an increased risk of thromboembolic events. However, the use of this common agent is fraught with complications and little is known regarding inter‐individual variation in warfarin response
In this thesis I use the most widely prescribed anticoagulant drug, warfarin, as a model to investig...
Objective: Genetic polymorphisms of CYP2C9 and VKORC1 play major role in pharmacokinetics and pharma...
Warfarin is one of the most commonly used oral anticoagulants worldwide and is highly efficacious fo...
Warfarin is a mainstay of therapy for conditions associated with an increased risk of thromboembolic...
Background: Warfarin is the most widely used oral anticoagulant for the prevention and treatment of ...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Warfarin is a potent drug that when used judiciously and monitored closely, leads to substantial red...
The genes encoding the cytochrome P450 2C9 enzyme (CYP2C9) and vitamin K-epoxide reductase complex u...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Aim:The study objectives were to investigate the association between selected CYP2C9 and VKORC1 sing...
This work was supported by the Wellcome Trust. The work was also supported by the Swedish Science Co...
Copyright © 2011 Marianne K. Kringen et al. This is an open access article distributed under the Cre...
Background: Warfarin has very narrow therapeutic windows and large individual variability. Genetic v...
Warfarin and other coumarin anticoagulants are widely used clinically, but currently dosing is deter...
We report the first genome-wide association study (GWAS) whose sample size (1,053 Swedish subjects) ...
In this thesis I use the most widely prescribed anticoagulant drug, warfarin, as a model to investig...
Objective: Genetic polymorphisms of CYP2C9 and VKORC1 play major role in pharmacokinetics and pharma...
Warfarin is one of the most commonly used oral anticoagulants worldwide and is highly efficacious fo...
Warfarin is a mainstay of therapy for conditions associated with an increased risk of thromboembolic...
Background: Warfarin is the most widely used oral anticoagulant for the prevention and treatment of ...
Warfarin is still the most clinically used oral anti-coagulant despite of its narrow therapeutic ind...
Warfarin is a potent drug that when used judiciously and monitored closely, leads to substantial red...
The genes encoding the cytochrome P450 2C9 enzyme (CYP2C9) and vitamin K-epoxide reductase complex u...
Warfarin is the most commonly used drug for chronic prevention of thromboembolic events, it also ran...
Aim:The study objectives were to investigate the association between selected CYP2C9 and VKORC1 sing...
This work was supported by the Wellcome Trust. The work was also supported by the Swedish Science Co...
Copyright © 2011 Marianne K. Kringen et al. This is an open access article distributed under the Cre...
Background: Warfarin has very narrow therapeutic windows and large individual variability. Genetic v...
Warfarin and other coumarin anticoagulants are widely used clinically, but currently dosing is deter...
We report the first genome-wide association study (GWAS) whose sample size (1,053 Swedish subjects) ...
In this thesis I use the most widely prescribed anticoagulant drug, warfarin, as a model to investig...
Objective: Genetic polymorphisms of CYP2C9 and VKORC1 play major role in pharmacokinetics and pharma...
Warfarin is one of the most commonly used oral anticoagulants worldwide and is highly efficacious fo...
DOI
Add to ORKG